Deep Learning-based Brain Tumor Detection System: Four-class Classification of MRI Images Using Convolutional Neural Networks

The deep learning-based brain tumor detection system introduced in this article uses Convolutional Neural Networks (CNN) to perform four-class classification (glioma, meningioma, pituitary tumor, no tumor) on brain MRI scan images, achieving a classification accuracy of 95.78%. Built using the TensorFlow and Keras frameworks, the system aims to address the issues of time-consuming manual interpretation of MRI images and susceptibility to subjective factors in traditional methods, providing AI-assisted support for clinical diagnosis.

Early and accurate diagnosis of brain tumors is crucial for treatment plans and prognosis. Traditional diagnosis relies on radiologists' manual interpretation of MRI images, which is time-consuming and susceptible to experience and subjective factors. With the growth of medical imaging data, AI-assisted diagnostic systems have become an important means to address insufficient medical resources and improve efficiency and accuracy. CNN has great potential in the field of medical image analysis.

Project Overview

The system classifies MRI images into four categories: glioma, meningioma, pituitary tumor, and no tumor.

CNN Design

It includes convolutional layers (to extract local features), pooling layers (to reduce dimensionality and enhance translation invariance), ReLU activation function, fully connected layers (to map to classification outputs), and Dropout regularization (to prevent overfitting).

Data Augmentation

Random rotation, flipping, scale transformation, brightness and contrast adjustment, cropping and padding are used to expand the dataset.

Preprocessing

Size normalization, pixel value normalization, grayscale processing, and noise removal.

Training Optimization

The loss function is categorical cross-entropy, the optimizer is Adam, with learning rate decay and early stopping mechanism to prevent overfitting.

The model achieved an accuracy of 95.78% on the test set, close to the level of junior radiologists. Category performance was analyzed using a confusion matrix, focusing on precision (reducing false positives), recall (reducing false negatives), and F1 score (comprehensive evaluation). A balance between these metrics is needed in medical scenarios.

1. Assisted Diagnosis: Provide doctors with a second opinion to aid decision-making;
2. Screening and Triage: Large-scale screening in resource-poor areas, prioritizing expert consultations;
3. Teaching and Training: Assist medical students in learning image features;
4. Telemedicine: Combine cloud-based analysis of images from primary hospitals to serve patients in remote areas.

1. Data Quality Dependence: Labeling errors, class imbalance, or quality issues in training data affect performance;
2. Generalization Ability: May lack generalization to images from other hospitals/devices;
3. Interpretability: The black-box nature of the model makes it difficult to explain decision-making basis;
4. Regulatory and Ethical Issues: Strict approval is required to address issues such as misdiagnosis liability and informed consent.

Future Directions

1. Multimodal Fusion: Combine different MRI sequences and modalities such as CT and PET;
2. Lesion Segmentation: Accurately label tumor boundaries and volume;
3. Prognosis Prediction: Combine clinical/genomic information to achieve personalized medicine;
4. Edge Deployment: Optimize the model to run on local devices to protect privacy.

Summary

The system identifies four types of brain tumors with an accuracy of 95.78%, providing strong assistance for clinical practice. Despite facing challenges, AI-assisted diagnosis will play an important role in healthcare in the future.